Synapse

← Jean‐Laurent Casanova

Papers by Jean‐Laurent Casanova

Page 1 · newest first

  1. Type I IFN autoantibodies in three of seven Europeans with life-threatening Usutu virus infectionJournal of Human Immunity · 2026
  2. The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenariansJournal of Human Immunity · 2026
  3. The ups and downs of human UNC93B1: Autoimmune and viral conditionsJournal of Human Immunity · 2026
  4. Clinical features of dominant and recessive interferon γ receptor 1 deficienciesThe Lancet · 2004
  5. Autosomal Recessive Cardiomyopathy Presenting as Acute MyocarditisJournal of the American College of Cardiology · 2017
  6. Mild Phenotype in Functionally Validated STAT1 Gain‐of‐Function Disease Due to a Novel DNA ‐Binding VariantScandinavian Journal of Immunology · 2026
  7. Autoantibodies neutralizing type I interferons in COVID-19 patients from southern BrazilJournal of Human Immunity · 2026
  8. Mycobacterial infections and recurrent osteomyelitis in a patient with an autosomal dominant mutation in IFN-gamma receptor 1 with overexpression of the receptorInternational Journal of Infectious Diseases · 2026
  9. Human inborn errors of the phagocyte respiratory burst: Chronic granulomatous disease and beyondJournal of Human Immunity · 2026
  10. High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis CJournal of Human Immunity · 2026
  11. Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitisProceedings of the National Academy of Sciences · 2026
  12. Autoantibodies neutralizing type I interferons in patients with life-threatening COVID-19 pneumonia: a meta-analysis from 2020–20262026
  13. Genetic and autoimmune predispositions to fulminant viral hepatitis in childrenFrontiers in Immunology · 2026
  14. High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesProceedings of the National Academy of Sciences · 2026
  15. Inborn errors of T cell topographic memory underlie organ-selective infectious diseases 2303844The Journal of Immunology · 2026
  16. Autosomal recessive OSMRβ deficiency: Connecting OSM and/or IL-31 with atopyJournal of Human Immunity · 2026
  17. Familial pulmonary alveolar proteinosis and type I interferonopathy by mutation of STAT2 (TIMS2)The Journal of Experimental Medicine · 2026
  18. Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosisThe Journal of Experimental Medicine · 2026
  19. ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtypeThe Journal of Experimental Medicine · 2026
  20. Allogeneic hematopoietic cell transplantation is curative in CARMIL2 deficiencyJournal of Human Immunity · 2026
  21. STAT1 gain-of-function in 12 Moroccan patients: Clinical and genetic insightsJournal of Human Immunity · 2026
  22. Inherited human TFIIIA deficiency disrupts T cell development2026
  23. Two novel kindreds with autosomal recessive STAT2 deficiencyJournal of Human Immunity · 2026
  24. Polyunsaturated fatty acid–derived lipid mediator patterns determine viral pneumonia severity and risk for critical COVID-19Proceedings of the National Academy of Sciences · 2026
  25. BIRC3 (Encoding cIAP2) Variants Result in Dysregulated RIPK1 Signaling Leading to Increased Epithelial Cell Death and Are Associated With Monogenic Crohn’s DiseaseGastroenterology · 2026
  26. Deleterious variants in the autophagy-related gene RB1CC1/FIP200 impair immunity to SARS-CoV-2Nature Communications · 2025
  27. Human inborn errors of the alternative NF-κB pathwayJournal of Human Immunity · 2025
  28. Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenzaThe Journal of Experimental Medicine · 2025
  29. OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2iScience · 2025
  30. Mendelian susceptibility to mycobacterial disease: Clinical, immunological, and genetic study in IndiaJournal of Human Immunity · 2025
  31. Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitisThe Journal of Experimental Medicine · 2025
  32. Type I IFNs Decrease SARS-CoV-2 Replication in Human Cardiomyocytes and Increase Cytokine Production in MacrophagesJournal of Clinical Immunology · 2025
  33. A novel heterozygous pathogenic AIRE variant causing autoimmunity but not infectious susceptibility2025
  34. Abundant Yet Aberrant T Helper Cell Responses to Candida albicans Underlie Mucosal Candidiasis in Humans and MiceEuropean Journal of Immunology · 2025
  35. Auto-Abs against type I IFNs: Strong, common, and global determinants of severe arboviral diseasesJournal of Human Immunity · 2025
  36. Novel genotypes, phenotypes, and triggers in humans with OTULIN haploinsufficiency2025
  37. Inherited IL-18BP deficiency in two Egyptian siblings with fulminant viral hepatitis2025
  38. The seven enigmas of SARS-CoV-2: From the past to the futureJournal of Human Immunity · 2025
  39. The potential impacts of human genetics on virus emergenceProceedings of the National Academy of Sciences · 2025
  40. Mepolizumab treatment in a child with inherited TYK2 deficiency2025
  41. Human inborn errors of type I interferon–independent intrinsic immunity in nonleukocytic cellsCurrent Opinion in Immunology · 2025
  42. Re-evaluation of the contribution of TNFRSF13B variants to antibody deficiency2025
  43. Intronic branchpoint-to-acceptor variants underlying inborn errors of immunity2025
  44. Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patientsJournal of Human Immunity · 2025
  45. Human LY9 governs CD4 ⁺ T cell IFN-γ immunity to Mycobacterium tuberculosisScience Immunology · 2025
  46. TRIM23 mediates cGAS-induced autophagy in anti-HSV defenseNature Communications · 2025
  47. Rapid Detection of Anti‐IFN‐α2 Autoantibodies Using a New Automated VIDAS Assay PrototypeEuropean Journal of Immunology · 2025
  48. Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profilesJournal of Clinical Investigation · 2025
  49. Role of clonal inflammatory microglia in histiocytosis-associated neurodegenerationNeuron · 2025
  50. Human genetics of Whipple's diseaseCurrent Opinion in Rheumatology · 2025